2024-03-28T19:04:45Zhttp://buleria.unileon.es/oai/requestoai:buleria.unileon.es:10612/84232020-12-10T09:04:33Zcom_10612_17col_10612_18
Protective effect of quercetin treatment on HFD-induced intestinal dysbiosis and barrier dysfunction in an in vivo model of non-alcoholic fatty liver disease
Porras, David
García-Mediavilla, María Victoria
Nistal, María Esther
Martínez-Flórez, Susana
Pisonero-Vaquero, Sandra
Jorquera, F.
Olcoz Goñi, José Luis
Jover Atienza, Ramiro
González-Gallego, Javier
Sánchez-Campos, Sonia
Otros
Medicina. Salud
1 p.
Gut microbiota is involved in obesity,
metabolic syndrome and nonalcoholic fatty liver disease (NAFLD).
Quercetin may have the ability to modulate the intestinal microbiota
composition, suggesting therapeutic potential in NAFLD. The present
study aims to investigate the beneficial effect of quercetin treatment
on dysbiosis, intestinal barrier dysfunction and gut-liver axis
alteration in high-fat diet (HFD)-fed mice. Resumen de un trabajo resultado del proyecto de investigación financiado por la Consejería de Educación de la Junta de Castilla y León (referencia LE063U16)
2018-07-31T13:08:08Z
2018-07-31T13:08:08Z
2018-07-31
info:eu-repo/semantics/article
Journal of Hepatology, 2017, 66
http://hdl.handle.net/10612/8423
Elsevier